Congress’s decision to push the “sequester” deadline to March 1, part of the bargain reached this week to keep the country from careening off the much-ballyhooed “fiscal cliff,” gives the healthcare industry a little breathing room before mandatory, across-the-board budget cuts could go into effect. Among the potential effects of the sequester is a 7 percent reduction in the Food and Drug Administration’s $4.5 billion budget for 2013. This ultimately ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.

Already registered? here.